Ritalin is the most widely recognised brand name for methylphenidate hydrochloride, a central nervous system stimulant that has been a cornerstone treatment for attention deficit hyperactivity disorder (ADHD) since the 1960s. The medication is also approved in many countries for narcolepsy and, less commonly, for treatment-resistant depression or cognitive impairment in specific medical contexts. Methylphenidate […]